通过pAKT-ADH4通路,TSA减轻了c-Myc驱动的肝癌发生的进展
Yang Liu1,2, Juan Yu1, Xiaotong An1
1Sinopharm Dongfeng General Hospital, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, 442000, People's Republic of China.
BMC cancer
|August 26, 2024
概括
三素A (TSA) 通过恢复酒精脱酶4 (ADH4) 表达和通过AKT-mTOR途径调节能量代谢,有效地治疗小鼠的c-Myc诱导肝细胞癌 (HCC).
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝脏恶性瘤,通常与放大c-Myc瘤基因有关.
- 基因组脱乙酶抑制剂 (HDACi),像Trichostatin A (TSA) 一样,显示出对HCC治疗的希望,但它们在c-Myc诱导的HCC中的机制尚未完全理解.
研究的目的:
- 在c-Myc诱导的HCC小鼠模型中研究TSA的治疗效果和分子机制.
- 确定TSA治疗在HCC中影响的关键分子标和途径.
主要方法:
- 在TSA治疗研究中使用了c-Myc诱导的HCC小鼠模型.
- 通过mRNA测序评估肝功能指标 (ALT,AST),脂质积累 (油红色染色) 和基因表达.
- 通过QPCR,免疫组织化学和西方 blot.使用验证的目标基因 (ADH4) 表达.
- 分析了细胞能量代谢物 (NAD+,NADH,ATP) 和信号通路 (AKT,mTOR).
主要成果:
- 治疗TSA延迟了HCC的发展,改善了肝功能标志物.
- 在HCC组织中,TSA减弱的脂质积累.
- TSA恢复了酒精脱酶4 (ADH4) 的表达,该表达被c-Myc.抑制.
- TSA调节了细胞能量水平,并降低了酸化的AKT (p-AKT) 和mTOR (p-mTOR) 信号发送.
结论:
- TSA证明了对c-Myc诱导的HCC的治疗疗效.
- AKT-mTOR-ADH4通路是TSA发挥其作用的关键机制.
- 通过向瘤性途径和代谢失调,TSA提供了作为HCC治疗的潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K


